• Je něco špatně v tomto záznamu ?

Synthesis and antiangiogenic activity of new silybin galloyl esters

R. Gažák, K. Valentová, K. Fuksová, P. Marhol, M. Kuzma, MÁ. Medina, I. Oborná, J. Ulrichová, V. Křen,

. 2011 ; 54 (20) : 7397-7407. [pub] 20111003

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022402

The synthesis of various silybin monogalloyl esters was developed, and their antiangiogenic activities were evaluated in a variety of in vitro tests with human umbilical vein endothelial cells (HUVECs). A structure-activity relationship (SAR) study found the regioselectivity of the silybin galloylation to be highly significant. Silybin (as an equimolar mixture of two diastereomers A and B) exhibited quite poor antiangiogenic activities, whereas its B stereoisomer is more active than silybin A. The galloylation of phenolic OH groups of natural silybin (a mixture of both isomers) leads to increases in their antiangiogenic activities, which is more apparent with the 7-OH than the 20-OH. In contrast, gallates at aliphatic OH groups either had a comparable activity to the parent compound or are even worse than silybin, which was observed in the case of 3-O-galloylsilybin. The most effective compound from this series (7-O-galloylsilybin) has also been prepared from stereochemically pure silybins A and B to evaluate the effect of stereochemistry on the activity. As with silybin itself, the B isomer of 7-O-galloylsilybin was more active than the A isomer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022402
003      
CZ-PrNML
005      
20170410101338.0
007      
ta
008      
120806s2011 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1021/jm201034h $2 doi
035    __
$a (PubMed)21928794
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gažák, Radek $u Centre of Biotransformation and Biocatalysis, Institute of Microbiology Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic.
245    10
$a Synthesis and antiangiogenic activity of new silybin galloyl esters / $c R. Gažák, K. Valentová, K. Fuksová, P. Marhol, M. Kuzma, MÁ. Medina, I. Oborná, J. Ulrichová, V. Křen,
520    9_
$a The synthesis of various silybin monogalloyl esters was developed, and their antiangiogenic activities were evaluated in a variety of in vitro tests with human umbilical vein endothelial cells (HUVECs). A structure-activity relationship (SAR) study found the regioselectivity of the silybin galloylation to be highly significant. Silybin (as an equimolar mixture of two diastereomers A and B) exhibited quite poor antiangiogenic activities, whereas its B stereoisomer is more active than silybin A. The galloylation of phenolic OH groups of natural silybin (a mixture of both isomers) leads to increases in their antiangiogenic activities, which is more apparent with the 7-OH than the 20-OH. In contrast, gallates at aliphatic OH groups either had a comparable activity to the parent compound or are even worse than silybin, which was observed in the case of 3-O-galloylsilybin. The most effective compound from this series (7-O-galloylsilybin) has also been prepared from stereochemically pure silybins A and B to evaluate the effect of stereochemistry on the activity. As with silybin itself, the B isomer of 7-O-galloylsilybin was more active than the A isomer.
650    _2
$a inhibitory angiogeneze $x chemická syntéza $x chemie $x farmakologie $7 D020533
650    _2
$a buněčná diferenciace $x účinky léků $7 D002454
650    _2
$a pohyb buněk $x účinky léků $7 D002465
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a kolagen $7 D003094
650    _2
$a fixní kombinace léků $7 D004338
650    _2
$a endoteliální buňky $x účinky léků $x fyziologie $7 D042783
650    _2
$a estery $7 D004952
650    _2
$a kyselina gallová $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D005707
650    _2
$a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
650    _2
$a lidé $7 D006801
650    _2
$a laminin $7 D007797
650    _2
$a proteoglykany $7 D011509
650    _2
$a silymarin $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D012838
650    _2
$a stereoizomerie $7 D013237
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Valentová, Kateřina
700    1_
$a Fuksová, Kateřina
700    1_
$a Marhol, Petr
700    1_
$a Kuzma, Marek
700    1_
$a Medina, Miguel Ángel
700    1_
$a Oborná, Ivana
700    1_
$a Ulrichová, Jitka
700    1_
$a Křen, Vladimír
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 54, č. 20 (2011), s. 7397-7407
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21928794 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20170410101636 $b ABA008
999    __
$a ok $b bmc $g 944315 $s 779699
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 54 $c 20 $d 7397-7407 $e 20111003 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
LZP    __
$a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...